𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of colorectal cancer in relatives of patients with inflammatory bowel disease (Denmark)

✍ Scribed by Jørn Olsen; Kirsten Fonager; Henrik Toft Sørensen; Lene Mellemkjær; Jørgen H. Olsen

Book ID
110268122
Publisher
Springer Netherlands
Year
1998
Tongue
English
Weight
69 KB
Volume
9
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Aminosalicylic acid therapy and the ri
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
✍ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective

Chemoprophylaxis of colorectal cancer in
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts
✍ Jonathan S. Levine; Robert Burakoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa

Two distinct groups of colorectal cancer
Two distinct groups of colorectal cancer in inflammatory bowel disease
✍ Stephan Brackmann; Solveig Norheim Andersen; Geir Aamodt; Borghild Roald; Frøydi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

## Background: The histological variability in colitis-associated colorectal cancer (crc in inflammatory bowel disease [ibd]) and the association to clinical factors is unknown. ## Methods: In population-based material including 67 patients with crc in ibd, histopathology of the cancers and tissu